Business directory profile

Acucela Inc.


acucela.com


Access Company Details

Acucela Inc.

Office phone +1 425-527-****
Get Phone Number

Homepage http://www.acucela.com
LinkedIn Profile https://linkedin.com/company/ac***a-in***
HQ Location United States , Washington, Seattle
1301 Second Avenue Suite 4200 Seattle, WA 98101-3805 United States
Last Update 2019-11-09
Manage your Business
Acucela Inc. (www.acucela.com or www.acucela.jp) is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.



Biotechnology and Molecular Biology Research

Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.

Career Opportunities at Acucela Inc.






Details of Acucela

Founded in
2002
Services
Opcensoredcen
Ophthcensoredc enso redcenso redcens oredcens
Industry
Biotechnology and Molecular Biology Research
Company Type
Private Company
Enterprise Size
censo redcens
Headquartered
United States, Washington, Seattle
Website
http://www.acucela.com


Related Companies and Competitors




Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.